Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
Alzheimer’s blood test to be used in memory-loss prevention trial
By
Alicia Lasek
Nov 12, 2021
The PrecivityAD blood test will lower barriers to participation in a new clinical trial that aims to prevent the symptoms of Alzheimer’s disease, researchers say.
Clinical briefs for Monday, June 5
By
Alicia Lasek
Jun 05, 2023
Memory support neighborhood takes ‘dignified approach’ to dementia care … Bias in test of lung function leaves up to 40% of Black males undiagnosed … FDA revokes EUA for J&J’s COVID vaccine...
COVID-19 may be a new risk factor for chronic pain, national study finds
By
Alicia Lasek
Jun 30, 2023
Fully 26% of study participants with moderate to severe COVID-19 symptoms reported frequent pain, researchers report.
FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
25 percent of COVID patients have post-acute symptoms; Report highlights emerging care needs
By
Alicia Lasek
Jun 18, 2021
A analysis based on nearly two million private U.S. healthcare claims has identified the most common post-COVID conditions with a focus on age, gender, mental health conditions and mortality. Even 19%...
One sick worker linked to 17 infections and $12K in treatment costs, LTC study finds
By
John Hall
Aug 26, 2022
A new study reveals how a single sick caregiver can easily infect residents and co-workers in a long-term care setting and drive up treatment costs by thousands of dollars.
HHS sets national plan to ‘end cancer as we know it’
By
Alicia Lasek
Apr 04, 2023
A new framework sets goals for early detection and prevention; development of effective treatments; eliminating cancer-care related inequalities; and supporting optimal care delivery.
Most US adults with type 2 diabetes meet criteria for GLP-RAs, SGLT2is
Feb 28, 2023
More than 82% US adults with type 2 diabetes meet the criteria to be prescribed the drugs, yet only 9% use either of them.